Financial statements Symbioz
Balance sheet of Symbioz
Company age:
Age:
7 y. 1 m. 12 d.
Share capital:
Share capital:
60 000 PLN
Balance sheet data of SYMBIOZ
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 744 361,26 | 615 530,60 | 1 887 090,05 | 3 215 229,84 | 4 225 906,92 |
| A. Fixed assets | 2 553,31 | 4 465,75 | 4 954,06 | 63 729,66 | 313 045,79 |
| B. Current assets | 741 807,95 | 611 064,85 | 1 882 135,99 | 3 151 500,18 | 3 912 861,13 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 744 361,26 | 615 530,60 | 1 887 090,05 | 3 215 229,84 | 4 225 906,92 |
| A. Equity | 2 198,42 | 23 220,64 | 370 847,16 | 421 636,01 | 445 178,12 |
| B. Liabilities and provisions for liabilities | 742 162,84 | 592 309,96 | 1 516 242,89 | 2 793 593,83 | 3 780 728,80 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 725 000,00 | 1 741 339,40 |
| II. Short-term liabilities | 742 162,84 | 592 309,96 | 1 516 242,89 | 2 045 074,91 | 2 019 355,76 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.